Locations:

Tag: samir kapadia

March 13, 2018/Heart, Vascular and Thoracic/Research

Time to Reperfusion for In-Hospital STEMI: Dramatic Gains Achievable with Comprehensive Protocol

Study shows progress from rethinking processes for a vulnerable population

March 13, 2018/Heart, Vascular and Thoracic/News & Insights

CMS Algorithm for Public Reporting of Door-to-Balloon Time Inflates Hospital Performance

Analysis suggests need for strategies to better reflect STEMI care quality

March 10, 2018/Heart, Vascular and Thoracic/Advancing Patient Care

STEMI Protocol Bridges Gender Gap in Care and Outcomes

Gains from new STEMI care processes are especially pronounced in women

March 6, 2018/Heart, Vascular and Thoracic/Advancing Patient Care

Process Improvement Initiatives Drive Dramatic Gains in Cath Lab Efficiency, Productivity

How Cleveland Clinic got a handle on a universal challenge

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

percutaneous-mitral-valve-procedure_650x450

October 23, 2017/Heart, Vascular and Thoracic/Research

Percutaneous Mending of the Mitral Valve: A Status Report on Challenges and Progress

Profile of six ongoing studies aiming to overcome anatomic hurdles

June 22, 2017/Heart, Vascular and Thoracic/News & Insights

Embolic Protection During TAVR: Who Should Get It? (Video)

Insights from the PI of the SENTINEL trial

June 15, 2017/Heart, Vascular and Thoracic/News & Insights

Cerebral Protection in TAVR: Approval Marks Start of a New Era

Safety considerations prevail in FDA decision on Sentinel device

January 17, 2017/Heart, Vascular and Thoracic/Technology & Innovation

First Implant of a Transcatheter Tricuspid Valved Stent Marks New Frontier in Percutaneous Valve Care

Promising new option for severe tricuspid regurgitation

October 27, 2015/Heart, Vascular and Thoracic/Research

TAVR’s Reach Expands with Approval of New Indications and Next-Generation Valves

FDA approvals for valve-in-valve TAVR follow clearance of 3rd-generation valve

March 15, 2015/Heart, Vascular and Thoracic/Technology & Innovation

5-Year PARTNER 1B Results: TAVR Remains Superior to Standard Therapy for Inoperable Aortic Stenosis

Final outcomes report changes treatment paradigm

BackPage 2 of 2Next